A Phase 1, Open-Label, Multicenter Study to Assess Safety, Tolerability, PK, and Efficacy of MK-1084 as Monotherapy and in Combination with Pembrolizumab in Subjects with KRASG12C Mutant Advanced Solid Tumors

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date20/12/21 → 19/12/26

Keywords

  • phase 1 study
  • multicentre trial
  • solid tumour
  • treatment safety
  • treatment efficacy